| 1 |
Genomic technologies for detecting structural variations in hematologic malignanciesGenomic technologies for detecting structural variations in hematologic malignancies
Mi-Ae JangMi-Ae Jang
KMSID: 1516086299 Blood Res. 2024;59:1. Published online 2024 February 13 DOI: http://dx.doi.org/10.1007/s44313-024-00001-1 |
|
| 2 |
Adding MYC/BCL2 double expression to NCCN‑IPI may not improve prognostic value to an acceptable levelAdding MYC/BCL2 double expression to NCCN‑IPI may not improve prognostic value to an acceptable level
Naree Warnnissorn, Nonglak Kanitsap, Pimjai Niparuck, Paisarn Boonsakan, Prapasri Kulalert, Wasithep Limvorapitak, Lantarima Bhoopat, Supawee Saengboon, Chinnawut Suriyonplengsaeng, Pichika Chantrathammachart, Teeraya Puavilai, Suporn ChuncharuneeNaree Warnnissorn, Nonglak Kanitsap, Pimjai Niparuck, Paisarn Boonsakan, Prapasri Kulalert, Wasithep Limvorapitak, Lantarima Bhoopat, Supawee Saengboon, Chinnawut Suriyonplengsaeng, Pichika Chantrathammachart, Teeraya Puavilai, Suporn Chuncharunee
KMSID: 1516086298 Blood Res. 2024;59:2. Published online 2024 February 19 DOI: http://dx.doi.org/10.1007/s44313-024-00006-w |
|
| 3 |
Real‑world incidence and risk factors of bortezomib‑related cardiovascular adverse events in patients with multiple myelomaReal‑world incidence and risk factors of bortezomib‑related cardiovascular adverse events in patients with multiple myeloma
Bitna Jang, Jonghyun Jeong, Kyu-Nam Heo, Youngil Koh, Ju-Yeun LeeBitna Jang, Jonghyun Jeong, Kyu-Nam Heo, Youngil Koh, Ju-Yeun Lee
KMSID: 1516086297 Blood Res. 2024;59:3. Published online 2024 February 19 DOI: http://dx.doi.org/10.1007/s44313-024-00004-y |
|
| 4 |
Upregulation of lnc‑FOXD2‑AS1, CDC45, and CDK1 in patients with primary non‑M3 AML is associated with a worse prognosisUpregulation of lnc‑FOXD2‑AS1, CDC45, and CDK1 in patients with primary non‑M3 AML is associated with a worse prognosis
Saba Manoochehrabadi, Morteza Talebi, Hossein Pashaiefar, Soudeh Ghafouri-Fard, Mohammad Vaezi, Mir Davood Omrani, Mohammad AhmadvandSaba Manoochehrabadi, Morteza Talebi, Hossein Pashaiefar, Soudeh Ghafouri-Fard, Mohammad Vaezi, Mir Davood Omrani, Mohammad Ahmadvand
KMSID: 1516086301 Blood Res. 2024;59:4. Published online 2024 February 19 DOI: http://dx.doi.org/10.1007/s44313-024-00002-0 |
|
| 5 |
Peripheral T‑cell lymphoma, NOS in bone marrow and heartPeripheral T‑cell lymphoma, NOS in bone marrow and heart
Hye Won Lee, Ja Young LeeHye Won Lee, Ja Young Lee
KMSID: 1516086296 Blood Res. 2024;59:5. Published online 2024 February 26 DOI: http://dx.doi.org/10.1007/s44313-024-00009-7 |
|
| 6 |
Comparable outcomes with low‑dose and standard‑dose horse anti‑thymocyte globulin in the treatment of severe aplastic anemiaComparable outcomes with low‑dose and standard‑dose horse anti‑thymocyte globulin in the treatment of severe aplastic anemia
Arihant Jain, Aditya Jandial, Thenmozhi Mani, Kamal Kishore, Charanpreet Singh, Deepesh Lad, Gaurav Prakash, Alka Khadwal, Reena Das, Neelam Varma, Subhash Varma, Pankaj MalhotraArihant Jain, Aditya Jandial, Thenmozhi Mani, Kamal Kishore, Charanpreet Singh, Deepesh Lad, Gaurav Prakash, Alka Khadwal, Reena Das, Neelam Varma, Subhash Varma, Pankaj Malhotra
KMSID: 1516086300 Blood Res. 2024;59:6. Published online 2024 February 26 DOI: http://dx.doi.org/10.1007/s44313-024-00003-z |
|
| 7 |
Gaucher or pseudo‑Gaucher cellsGaucher or pseudo‑Gaucher cells
Gurpreet Kaur, Ankur Ahuja, Ganesh Kumar Vishwananthan, Arijit SenGurpreet Kaur, Ankur Ahuja, Ganesh Kumar Vishwananthan, Arijit Sen
KMSID: 1516086341 Blood Res. 2024;59:7. Published online 2024 February 28 DOI: http://dx.doi.org/10.1007/s44313-024-00005-x |
|
| 8 |
Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA‑4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA‑4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)
Doaa Mohamed El Demerdash, Maha Mohamed Saber, Alia Ayad, Kareeman Gomaa, Mohamed Abdelkader MoradDoaa Mohamed El Demerdash, Maha Mohamed Saber, Alia Ayad, Kareeman Gomaa, Mohamed Abdelkader Morad
KMSID: 1516086339 Blood Res. 2024;59:8. Published online 2024 March 1 DOI: http://dx.doi.org/10.1007/s44313-024-00011-z |
|
| 9 |
Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta‑analysisImpact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta‑analysis
Imen Frikha, Rim Frikha, Moez Medhaffer, Hanen Charfi, Fatma Turki, Moez ElloumiImen Frikha, Rim Frikha, Moez Medhaffer, Hanen Charfi, Fatma Turki, Moez Elloumi
KMSID: 1516086344 Blood Res. 2024;59:9. Published online 2024 March 4 DOI: http://dx.doi.org/10.1007/s44313-024-00007-9 |
|
| 10 |
Acute erythroid leukemia leading to the diagnosis of Schwachman‑Diamond syndromeAcute erythroid leukemia leading to the diagnosis of Schwachman‑Diamond syndrome
Bernhard Strasser, Sebastian Mustafa, Josef Tomasits, Alexander HaushoferBernhard Strasser, Sebastian Mustafa, Josef Tomasits, Alexander Haushofer
KMSID: 1516086342 Blood Res. 2024;59:10. Published online 2024 March 6 DOI: http://dx.doi.org/10.1007/s44313-024-00008-8 |
|
| 11 |
The role of next‑generation sequencing in hematologic malignanciesThe role of next‑generation sequencing in hematologic malignancies
Young‑Uk ChoYoung‑Uk Cho
KMSID: 1516086343 Blood Res. 2024;59:11. Published online 2024 March 6 DOI: http://dx.doi.org/10.1007/s44313-024-00010-0 |
|
| 12 |
Genomic testing for germline predisposition to hematologic malignanciesGenomic testing for germline predisposition to hematologic malignancies
Sang Mee HwangSang Mee Hwang
KMSID: 1516086340 Blood Res. 2024;59:12. Published online 2024 March 8 DOI: http://dx.doi.org/10.1007/s44313-024-00012-y |
|
| 13 |
Rare pseudo‑chediak‑higashi inclusions in a patient with disseminated diffuse large B cell lymphomaRare pseudo‑chediak‑higashi inclusions in a patient with disseminated diffuse large B cell lymphoma
Can Yan, Zenghui Fang, Jinlin LiuCan Yan, Zenghui Fang, Jinlin Liu
KMSID: 1516086775 Blood Res. 2024;59:13. Published online 2024 March 25 DOI: http://dx.doi.org/10.1007/s44313-024-00013-x |
|
| 14 |
Transfusion‑transmitted infectionsTransfusion‑transmitted infections
Han Joo Kim, Dae‑Hyun KoHan Joo Kim, Dae‑Hyun Ko
KMSID: 1516086840 Blood Res. 2024;59:14. Published online 2024 April 12 DOI: http://dx.doi.org/10.1007/s44313-024-00014-w |
|
| 15 |
What is new in acute myeloid leukemia classification?What is new in acute myeloid leukemia classification?
Hee Sue ParkHee Sue Park
KMSID: 1516086841 Blood Res. 2024;59:15. Published online 2024 April 12 DOI: http://dx.doi.org/10.1007/s44313-024-00016-8 |
|
| 16 |
Abnormal frequency of the memory B cell subsets and plasmablasts in patients with congenital severe hemophilia A: correlation with “Inhibitor” formationAbnormal frequency of the memory B cell subsets and plasmablasts in patients with congenital severe hemophilia A: correlation with “Inhibitor” formation
Omid Reza Zekavat, Yasaman Movahednezhad, Amin Shahsavani, Sezaneh Haghpanah, Negin Shokrgozar, Hossein Golmoghaddam, Mehdi Kalani, Mohammad Reza Bordbar, Nargess ArandiOmid Reza Zekavat, Yasaman Movahednezhad, Amin Shahsavani, Sezaneh Haghpanah, Negin Shokrgozar, Hossein Golmoghaddam, Mehdi Kalani, Mohammad Reza Bordbar, Nargess Arandi
KMSID: 1516087110 Blood Res. 2024;59:16. Published online 2024 April 16 DOI: http://dx.doi.org/10.1007/s44313-024-00017-7 |
|
| 17 |
Correction: Abnormal frequency of the memory B cell subsets and plasmablasts in patients with congenital severe hemophilia A: correlation with “Inhibitor” formationCorrection: Abnormal frequency of the memory B cell subsets and plasmablasts in patients with congenital severe hemophilia A: correlation with “Inhibitor” formation
Omid Reza Zekavat, Yasaman Movahednezhad, Amin Shahsavani, Sezaneh Haghpanah, Negin Shokrgozar, Hossein Golmoghaddam, Mehdi Kalani, Mohammad Reza Bordbar, Nargess ArandiOmid Reza Zekavat, Yasaman Movahednezhad, Amin Shahsavani, Sezaneh Haghpanah, Negin Shokrgozar, Hossein Golmoghaddam, Mehdi Kalani, Mohammad Reza Bordbar, Nargess Arandi
KMSID: 1516087626 Blood Res. 2024;59:17. Published online 2024 April 26 DOI: http://dx.doi.org/10.1007/s44313-024-00019-5 |
|
| 18 |
Pathologic characteristics of histiocytic and dendritic cell neoplasmsPathologic characteristics of histiocytic and dendritic cell neoplasms
KMSID: 1516087281 Blood Res. 2024;59:18. Published online 2024 May 7 DOI: http://dx.doi.org/10.1007/s44313-024-00015-9 |
|
| 19 |
Assessment of the phenotypic severity of hemophilia A: using rotational thromboelastometry (ROTEM) and APTT‑clot waveform analysisAssessment of the phenotypic severity of hemophilia A: using rotational thromboelastometry (ROTEM) and APTT‑clot waveform analysis
Deepika Gupta, Vandana Arya, Jasmita Dass, Nitin Gupta, Manas Kalra, Anupam Sachdeva, Jyoti KotwalDeepika Gupta, Vandana Arya, Jasmita Dass, Nitin Gupta, Manas Kalra, Anupam Sachdeva, Jyoti Kotwal
KMSID: 1516087280 Blood Res. 2024;59:19. Published online 2024 May 14 DOI: http://dx.doi.org/10.1007/s44313-024-00018-6 |
|
| 20 |
Correction: MicroRNA‑765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cellsCorrection: MicroRNA‑765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cells
Seong‑Ho Kang, Ji Seon ChoiSeong‑Ho Kang, Ji Seon Choi
KMSID: 1516087279 Blood Res. 2024;59:20. Published online 2024 May 27 DOI: http://dx.doi.org/10.1007/s44313-024-00020-y |
|
| 21 |
Preoperative consultation for determining the appropriate transfusion strategyPreoperative consultation for determining the appropriate transfusion strategy
Ka‑Won KangKa‑Won Kang
KMSID: 1516087282 Blood Res. 2024;59:21. Published online 2024 June 7 DOI: http://dx.doi.org/10.1007/s44313-024-00021-x |
|
| 22 |
Advancements in the understanding and management of histiocytic neoplasmsAdvancements in the understanding and management of histiocytic neoplasms
Kyung‑Nam Koh, Su Hyun Yoon, Sung Han Kang, Hyery Kim, Ho Joon ImKyung‑Nam Koh, Su Hyun Yoon, Sung Han Kang, Hyery Kim, Ho Joon Im
KMSID: 1516088016 Blood Res. 2024;59:22. Published online 2024 July 4 DOI: http://dx.doi.org/10.1007/s44313-024-00022-w |
|
| 23 |
Treatment with ropeginterferon alfa‑2b in patients with hydroxyurea resistant or intolerant polycythemia vera in South Korea: one‑year results from a phase 2 studyTreatment with ropeginterferon alfa‑2b in patients with hydroxyurea resistant or intolerant polycythemia vera in South Korea: one‑year results from a phase 2 study
Seug Yun Yoon, Sung‑Eun LeeSeug Yun Yoon, Sung‑Eun Lee
KMSID: 1516088018 Blood Res. 2024;59:23. Published online 2024 July 9 DOI: http://dx.doi.org/10.1007/s44313-024-00026-6 |
|
| 24 |
Comparative efficacy of VMP vs. Rd in newly diagnosed, autologous stem cell transplant‑ineligible multiple myeloma patients: a prematurely terminated randomized controlled study, CAREMM‑2002 studyComparative efficacy of VMP vs. Rd in newly diagnosed, autologous stem cell transplant‑ineligible multiple myeloma patients: a prematurely terminated randomized controlled study, CAREMM‑2002 study
Cheong Yoon Huh, Sung‑Soo Park, Jung Yeon Lee, Chang‑Ki MinCheong Yoon Huh, Sung‑Soo Park, Jung Yeon Lee, Chang‑Ki Min
KMSID: 1516088019 Blood Res. 2024;59:24. Published online 2024 July 17 DOI: http://dx.doi.org/10.1007/s44313-024-00025-7 |
|
| 25 |
Proper application of anticoagulation therapy on cancer‑associated venous thrombosisProper application of anticoagulation therapy on cancer‑associated venous thrombosis
Ho‑Young YhimHo‑Young Yhim
KMSID: 1516088017 Blood Res. 2024;59:25. Published online 2024 August 2 DOI: http://dx.doi.org/10.1007/s44313-024-00029-3 |
|
| 26 |
Functional iron deficiency anemia in patients with cancerFunctional iron deficiency anemia in patients with cancer
Jeong Suk Koh, Ik‑Chan SongJeong Suk Koh, Ik‑Chan Song
KMSID: 1516088020 Blood Res. 2024;59:26. Published online 2024 August 7 DOI: http://dx.doi.org/10.1007/s44313-024-00030-w |
|
| 27 |
Clinical data on treatment regimen and use of medication among patients with hemophilia B in KoreaClinical data on treatment regimen and use of medication among patients with hemophilia B in Korea
Young Shil Park, Ji Kyoung Park, Jeong A Park, Hee Jo Baek, Jae Hee Lee, Chur Woo You, Chuhl Joo Lyu, Eun Jin ChoiYoung Shil Park, Ji Kyoung Park, Jeong A Park, Hee Jo Baek, Jae Hee Lee, Chur Woo You, Chuhl Joo Lyu, Eun Jin Choi
KMSID: 1516088021 Blood Res. 2024;59:27. Published online 2024 August 8 DOI: http://dx.doi.org/10.1007/s44313-024-00024-8 |
|
| 28 |
Monoclonal gammopathy of renal significance from the perspective of nephrologistsMonoclonal gammopathy of renal significance from the perspective of nephrologists
Kootae Park, Soon Hyo KwonKootae Park, Soon Hyo Kwon
KMSID: 1516088077 Blood Res. 2024;59:28. Published online 2024 August 12 DOI: http://dx.doi.org/10.1007/s44313-024-00027-5 |
|
| 29 |
Evaluation of FVIII pharmacokinetic profiles in Korean hemophilia A patients assessed with myPKFiT: a retrospective chart reviewEvaluation of FVIII pharmacokinetic profiles in Korean hemophilia A patients assessed with myPKFiT: a retrospective chart review
Young‑Shil Park, Ki‑Young Yoo, Sang Kyu Park, Taiju Hwang, Aeran Jung, Eun Jin ChoiYoung‑Shil Park, Ki‑Young Yoo, Sang Kyu Park, Taiju Hwang, Aeran Jung, Eun Jin Choi
KMSID: 1516088078 Blood Res. 2024;59:29. Published online 2024 August 28 DOI: http://dx.doi.org/10.1007/s44313-024-00023-9 |
|
